IMPROVING QUALITY OF LIFE

Fundamentals of Glaucoma Pub Date : 2020-09-02 DOI:10.1142/9789811216459_0008

Katie Smith, P. Adams

引用次数: 0

Abstract

• Increase of Operating EBITA with 22% to €66 million (Q3 2019: €54 million), resulting in operating margin of 10.9% (Q3 2019: 8.4%) • Excellent free cash flow of €119 million (Q3 2019: €4 million) • Strengthened balance sheet and successfully completed €150 million re-financing • Grown backlog with 4% compared to Q2 2020 and year-to-date 6% • Arcadis organization and business continues to proof resilience • Decision to significantly reduce footprint in the Middle East • Non-cash goodwill/intangibles impairment for Middle East and CallisonRTKL of €126 million

查看原文本刊更多论文

提高生活质量

•运营EBITA增长22%至6600万欧元(2019年第三季度:5400万欧元)，营业利润率为10.9%(2019年第三季度:8.4%)•出色的自由现金流为1.19亿欧元(2019年第三季度:•加强资产负债表并成功完成1.5亿欧元的再融资•与2020年第二季度相比，积压业务增长4%，年初至今增长6%•Arcadis组织和业务继续证明弹性•决定大幅减少在中东的足迹•中东和CallisonRTKL的非现金商誉/无形资产减值为1.26亿欧元

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Fundamentals of Glaucoma

自引率

0.00%

发文量